Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 14 October 2027
- Last conf. stmt
- 30 September 2026
Advanz Pharma Europe Limited
- Incorporated
- 28 April 2016 (10 years)
- Previously known as
- Intercept Pharma Ltd (until 26 September 2022)This list may be incomplete. See all names on Companies House
- Industry
- Wholesale of pharmaceutical goods (46460)
- Directors
- Owned by
- Accounts type
- Dormant
- Region
- Greater London
- Address
- Dashwood House69 Old Broad StreetLondonEC2M 1QS
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 6 February 2025
British
Born June 1982 (44)
British
Born February 1973 (53)
Officer history (11 former)
6 February 2025
6 February 2025
31 December 2024
Resigned Barcelo Sanchez, Francisco Javier as Director
23 February 2024
23 February 2024
Resigned Notarianni, Giancarlo as Director
1 July 2022
1 July 2022
1 July 2022
1 July 2022
Appointed Barcelo Sanchez, Francisco Javier as Director
1 July 2022
Resigned Higson, Graham Charles as Director
29 October 2021
29 September 2021
Appointed Notarianni, Giancarlo as Director
18 May 2021
7 January 2021
15 December 2020
3 July 2020
3 July 2020
4 December 2017
Resigned Yoon, Seokho Bryan as Director
18 September 2017
Resigned Robertson, Linda Marontate, Dr as Director
28 April 2016
Appointed Yoon, Seokho Bryan as Director
28 April 2016
28 April 2016
28 April 2016
Appointed Higson, Graham Charles as Director
28 April 2016
Appointed Robertson, Linda Marontate, Dr as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 1 July 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 02330913
Former controllers (1)
1 July 2022
Ceased Intercept Pharmaceuticals, Inc. — Owns 75–100% of shares
Group structure 10 companies
Ownership group derived from the Companies House PSC register
Advanz Pharma Europe Limited This company Owns 75–100% of shares
Advanz Pharma Generics (UK) Limited Owns 75–100% of shares
Advanz Pharma Services (UK) Limited Owns 75–100% of shares
Advanz Pharma UK and Ireland Limited Owns 75–100% of shares
Amdipharm Mercury Midco UK Limited Owns 75–100% of shares
Amdipharm UK Limited Owns 75–100% of shares
Correvio (UK) Ltd. Owns 75–100% of shares
Focus Pharmaceuticals Limited Owns 75–100% of shares
Mercury Pharmaceuticals Limited Owns 75–100% of shares
Financials
Figures from 2023 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £2
- Debt Ratio
- 0%
Balance sheet detail
| 2023 | |
|---|---|
| Fixed Assets | £0 |
| Current Assets | £2 |
| Creditors (< 1 year) | £0 |
| Creditors (> 1 year) | £0 |
| Net Current Assets | £2 |
| Net Assets | £2 |
| Shareholder Funds | £2 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 12 November 2025 | Confirmation statement with no updates | 30 September 2025 | ||
| 21 October 2025 | Accounts for a dormant company | 31 December 2024 | ||
| 20 February 2025 | Appointment of a director | |||
| 19 February 2025 | Termination of appointment of a director | |||
| 8 January 2025 | Termination of appointment of a director |
Some other companies at this address
Other companies in this industry
Guildford
London
Wokingham
London
Newtownards
East Kilbride
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →